Page 5 of 11

RD7.2 | Imaging in Sensorineural Hearing Loss — SDL Guide (Part 2)

Impact on Diagnosis and Management — From Scan to Decision

RD7.2 sits at the knows-how level because the imaging finding in SNHL must be translated into a management decision — the scan determines whether a tumour is watched or operated, how a deaf child is counselled, and even whether an implant can be offered at all. The clinician who can read the IAM/CPA MRI and the temporal-bone CT can anticipate the pathway, counsel the patient accurately and recognise the findings that open or close a treatment option. The management decisions flow directly from the imaging, and tracing that chain is the applied core of this competency.

Pathway 1 — Vestibular schwannoma (size- and hearing-driven):
Management of a confirmed schwannoma is guided largely by its size, growth and the patient's hearing and age. Broadly:
- Small/intracanalicular tumours, especially in older patients → observation with serial MRI ('watchful waiting'), since many grow slowly or not at all.
- Small-to-medium tumours → stereotactic radiosurgery (e.g. Gamma Knife) to arrest growth, or hearing-preservation microsurgery depending on hearing status and patient choice.
- Large tumours compressing the brainstem → microsurgical excision. Serial MRI is the tool that documents growth and triggers escalation. The imaging finding therefore does not merely diagnose — it sets the entire management tempo.

Pathway 2 — Congenital SNHL and the cochlear implant decision:
In paediatric SNHL the scan answers a make-or-break question for rehabilitation. Enlarged vestibular aqueduct prompts counselling to avoid head trauma/contact sports (which can precipitate sudden drops) and audiological follow-up, with cochlear implantation if loss progresses to severe-profound. The pivotal finding is the status of the cochlear nerve: a present nerve and a patent cochlea make a child a candidate for a cochlear implant, whereas cochlear nerve aplasia contraindicates a cochlear implant (there is no nerve to stimulate) and redirects management toward an auditory brainstem implant. Labyrinthitis ossificans detected before the cochlea ossifies allows implantation to proceed urgently before the lumen is lost.

Pathway 3 — Other findings and pre-operative roadmap:
A meningioma or epidermoid at the CPA changes the surgical approach and the differential. Otosclerosis with a sensorineural component may be managed medically or surgically depending on the audiogram. Across all of these, the report's value lies in detail: the side and size of a tumour, the patency of the cochlea, the presence of the cochlear nerve and any anatomical variants (e.g. an aberrant facial nerve or a high jugular bulb) together form the surgical roadmap the operating team relies on.

Imaging-Guided Management in Sensorineural Hearing Loss

Self-Assessment — Integrating Imaging into SNHL Decisions

Work through these scenarios as if you are the clinician responsible for ordering and interpreting the imaging. Write your reasoning before reading the discussion, and in each case state explicitly which modality you would choose and how the finding changes management. Deliberately rehearsing the chain from the pattern of hearing loss, to the scan, to the decision is the exact skill RD7.2 assesses; it rewards clinical reasoning over rote lists, and it is the habit that prevents both missed tumours and unnecessary scans.

Scenario A: A 55-year-old man has a six-month history of progressive right-sided hearing loss with tinnitus and mild unsteadiness; audiometry shows a unilateral SNHL with disproportionately poor speech discrimination. What imaging do you request, what are you looking for, and what would a 1 cm enhancing IAM/CPA mass mean for management?

Discussion: Asymmetric SNHL with poor speech discrimination is a classic retrocochlear presentation, so the investigation is gadolinium-enhanced MRI of the IAM/CPA (with heavily T2 CISS/FIESTA), looking for a vestibular schwannoma. A 1 cm avidly enhancing IAM/CPA mass (ice-cream-cone if it extends into the angle) is a small-to-medium schwannoma; depending on the patient's hearing, age and preference, management options are observation with serial MRI, stereotactic radiosurgery, or hearing-preservation microsurgery. Serial MRI documents growth and triggers escalation.

Scenario B: A 4-year-old with congenital bilateral severe SNHL is being worked up for possible cochlear implantation. Which investigations are needed and why, and what two findings would most affect whether an implant is feasible?

Discussion: Pre-implant assessment needs HRCT temporal bone (bony labyrinth, cochlear patency and malformations, EVA) and MRI with CISS/FIESTA (cochlear nerve, fluid signal in the cochlea). The two findings that most affect feasibility are cochlear patency — labyrinthitis ossificans or a malformed/obliterated cochlea complicates or contraindicates implantation — and the presence of the cochlear nerve: cochlear nerve aplasia contraindicates a conventional cochlear implant (an auditory brainstem implant is then considered).

Scenario C: A 40-year-old develops profound hearing loss in one ear overnight (sudden SNHL) with no other neurological symptoms. Initial steroids are given by ENT. Is imaging needed, and if so what and why?

Discussion: Yes — although most sudden SNHL is idiopathic, MRI of the IAM/CPA is recommended to exclude a retrocochlear lesion (vestibular schwannoma can occasionally present as sudden loss) and central causes such as a brainstem infarct or demyelination. The imaging does not delay the initial steroid treatment but ensures a structural or sinister cause is not missed; HRCT is not the first choice here because the concern is neural/soft-tissue rather than bony.